• Een ontstekingsremmend proteïne

    Wednesday March 18th 2020

  • Statement on Corona virus (COVID-19) in regard to flanders.bio events

    Wednesday March 11th 2020

  • ImmunXperts acquired by Nexelis (Canada)

    Thursday March 5th 2020

  • Biocartis kondigt nieuw immuno-oncologie project aan met Bristol-Myers Squibb voor de registratie van de Idylla™ MSI test in China

    Thursday March 5th 2020

  • Biotalys announces second closing of €45 million Series C financing round

    Thursday March 5th 2020

  • Mithra Receives acceptance of Marketing Authorization Application (MAA) to market Estelle® in Belgium and Luxembourg

    Tuesday March 3rd 2020

  • Pivotal Acquires Akcelis, an Industry Leader in Patient Engagement, Recruitment and Retention

    Tuesday March 3rd 2020

  • EMA Accepts Richter’s Marketing Authorization Application (MAA) for Estelle®, a Novel Combined Oral Contraceptive

    Thursday February 27th 2020

  • Your news here?

  • iTeos Therapeutics Initiates Phase 1/2 Study with Highly Innovative Anti-TIGIT Antibody in Patients with Advanced Cancers

    Wednesday February 26th 2020

  • European Union and Flemish government support FOx Biosystems with €884 000

    Tuesday February 25th 2020

  • Imec ontwikkelt kleine radiozender voor elektronische pil

    Tuesday February 25th 2020


Strategic Partners